Micke O, Seegenschmiedt MH. Radiation therapy foraggressive fibromatosis (desmoid tumors): Results of anational Patterns of Care Study. Int J Rad Oncol Biol Phys.2005;61:882–91.
DOI: 10.1016/j.ijrobp.2004.07.705
Seegenschmiedt MH, Micke O, Niewald M, Mücke R, Eich HT,Kriz J, et al. DEGRO guidelines for the radiotherapy ofnon-malignant disorders: Part III: Hyperproliferativedisorders. Strahlenther Onkol. 2015. Publicación electrónica11 Mar 2015.
DOI: 10.1007/s00066-015-0818-2
Lev D, Kotilingam D, Wei C, Ballo MT, Zagars GK, Pisters PW,et al. Optimizing treatment of desmoid tumors. J Clin Oncol.2007;25:1785–91.
DOI: 10.1200/JCO.2006.10.5015
Kallam AR, Ramakrishna BV, Roy GK, Karthik KR. Desmoidtumours: Our experience of six cases and review of literature.J Clin Diagn Res. 2014;8:NE01–4.
DOI: 10.7860/JCDR/2014/9610.5032
Spear MA, Jennings LC, Mankin HJ, Spiro IJ, Springfield DS,Gebhardt MC<ET-AT>. Individualizing management ofaggressive fibromatoses. Int J Rad Oncol Biol Phys.1998;40:637–45.
DOI: 10.1016/S0360-3016(97)00845-6
Ballo MT, Zagars GK, Pollack A, Pisters PW, Pollack RA.Desmoid tumor: Prognostic factors and outcome aftersurgery, radiation therapy, or combined surgery and radiationtherapy. J Clin Oncol. 1999;17:158–67.
DOI: 10.1200/JCO.1999.17.1.158
Gronchi A, Casali PG, Mariani L, lo Vullo S, Colecchia M, LozzaL, et al. Quality of surgery and outcome in extra-abdominalaggressive fibromatosis: A series of patients surgically treatedat a single institution. J Clin Oncol. 2003;21:1390–7.
DOI: 10.1200/JCO.2003.05.150
Kirschner MJ, Sauer R. [The role of radiotherapy in thetreatment of desmoidtumors] Strahlentherapie undOnkologie. Strahlenther Onkol. 1993;169(2):77–82.
Gluck I, Griffith KA, Biermann JS, Feng FY, Lucas DR, Ben-JosefE. Role of radiotherapy in the management of desmoidtumors. Int J Rad Oncol Biol Phys. 2011;80:787–92.
DOI: 10.1016/j.ijrobp.2010.02.053
Roeder F, Timke C, Oertel S, Hensley FW, Bischof M, MuenterMW, et al. Intraoperative electron radiotherapy for themanagement of aggressive fibromatosis. Int J Radiat OncolBiol Phys. 2010;76:1154–60.
DOI: 10.1016/j.ijrobp.2009.03.067
Keus RB, Nout RA, Blay JY, de Jong JM, Hennig I, Saran F, et al.Results of a phase II pilot study of moderate doseradiotherapy for inoperable desmoid-type fibromatosis–anEORTC STBSG and ROG study (EORTC 62991-22998). AnnOncol. 2013;24:2672–6.
Chew C, Reid R, O’Dwyer PJ. Evaluation of the long termoutcome of patients with extremity desmoids. Eur J SurgOncol. 2004;30:428–32.
DOI: 10.1016/j.ejso.2004.01.010
Singer S, Maki R, O’Sullivan B. Soft tissue sarcoma cancer. En:DeVita V, Lawrence T, Rosenberg S, editores. Principles &Practice of Oncology. 9.aed. Filadelfia: Lippincott Williams&Wilkins; 2011. p. 1533–77.
Furukawa N, Nishioka K, Noguchi T, Kajihara H, Horie K.Port-site metastasis of mucinous borderline ovarian tumorafter laparoscopy. Case Rep Oncol. 2014;7:804–9.
DOI: 10.1159/000369994
Akram J, Wooler G, Lock-Andersen J. Dermatofibrosarcomaprotuberans: Clinical series, national Danish incidence dataand suggested guidelines. J Plast Surg Hand Surg.2014;48:67–73.
DOI: 10.3109/2000656X.2013.812969
Hamid R, Hafeez A, Darzi MA, Zaroo I, Rasool A, Rashid H.Outcome of wide local excision in dermatofibrosarcoma protuberans and use of radiotherapy for margin positivedisease. Indian Dermatol Online J. 2013;4:93–6.
DOI: 10.4103/2229-5178.110591
Castle KO, Guadagnolo BA, Tsai CJ, Feig BW, Zagars GK.Dermatofibrosarcoma protuberans: Long-term outcomes of53 patients treated with conservative surgery and radiationtherapy. Int J Rad Oncol Biol Phys. 2013;86:585–90.
DOI: 10.1016/j.ijrobp.2013.02.024
Williams N, Morris CG, Kirwan JM, Dagan R, Mendenhall WM,Radiotherapy for dermatofibrosarcoma protuberans. Am JClin Oncol. 2014;37:430–2.
DOI: 10.1097/COC.0b013e31827dee86
Número de descargas:
87402
Número de visitas:
2221
Citas:
0
